Food Safety Dx Firm Sample6 Raises $11M | GenomeWeb

NEW YORK (GenomeWeb News) – Food safety diagnostic test firm Sample6 today announced it has secured $11 million in a Series B financing round.

The funds will go toward commercialization of the Boston-based company's first products, Sample6 Detect/L, an assay for identifying Listeria contamination; and Sample6 Control, a software platform for planning, executing, remediating, and analyzing food safety programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.

Sponsored by
Agilent Technologies

This online seminar will discuss a metagenomic assay to identify viruses and other pathogenic microorganisms in human tumor samples, with the aim of gaining a more comprehensive understanding of the role of the microbiome in cancer development and treatment.